Healthcare provider profile · identity verified

John R Sashko, MD

Family Practice · LAKEWOOD, WA · NPI 1669483947

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	684	214
Amlodipine Besylate	Amlodipine Besylate	529	156
Lisinopril	Lisinopril	302	97
Metoprolol Succinate	Metoprolol Succinate	279	80
Losartan Potassium	Losartan Potassium	239	71
Levothyroxine Sodium	Levothyroxine Sodium	208	62
Gabapentin	Gabapentin	191	61
Omeprazole	Omeprazole	182	49
Hydrochlorothiazide	Hydrochlorothiazide	154	53
Albuterol Sulfate Hfa	Albuterol Sulfate	149	46
Metformin Hcl	Metformin Hcl	136	45
Trazodone Hcl	Trazodone Hcl	134	41
Pantoprazole Sodium	Pantoprazole Sodium	126	39
Rosuvastatin Calcium	Rosuvastatin Calcium	110	32
Glipizide Er	Glipizide	104	31
Tamsulosin Hcl	Tamsulosin Hcl	98	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	17
Fluoxetine Hcl	Fluoxetine Hcl	86	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	84	26
Furosemide	Furosemide	80	24
Alendronate Sodium	Alendronate Sodium	79	24
Simvastatin	Simvastatin	76	23
Allopurinol	Allopurinol	75	18
Famotidine	Famotidine	69	16
Metoprolol Tartrate	Metoprolol Tartrate	66	23
Metformin Hcl Er	Metformin Hcl	65	24
Potassium Chloride	Potassium Chloride	64	21
Carvedilol	Carvedilol	63	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	62	16
Meloxicam	Meloxicam	58	25
Sertraline Hcl	Sertraline Hcl	58	20
Clopidogrel	Clopidogrel Bisulfate	54	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	14
Oxycodone Hcl	Oxycodone Hcl	53	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	12
Pravastatin Sodium	Pravastatin Sodium	52	16
Finasteride	Finasteride	51	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	15
Venlafaxine Hcl Er	Venlafaxine Hcl	48	12
Bupropion Xl	Bupropion Hcl	45	12
Fluticasone Propionate	Fluticasone Propionate	44	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	12
Tramadol Hcl	Tramadol Hcl	39	13
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Tizanidine Hcl	Tizanidine Hcl	37	suppressed
Montelukast Sodium	Montelukast Sodium	36	14
Glimepiride	Glimepiride	35	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Levetiracetam	Levetiracetam	34	suppressed
Xarelto	Rivaroxaban	34	14
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Mounjaro	Tirzepatide	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	13
Ezetimibe	Ezetimibe	32	suppressed
Glipizide	Glipizide	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Alprazolam	Alprazolam	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Ibandronate Sodium	Ibandronate Sodium	31	12
Colestipol Hcl	Colestipol Hcl	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	21
Cephalexin	Cephalexin	28	23
Nifedipine Er	Nifedipine	28	suppressed
Prednisone	Prednisone	28	25
Clonazepam	Clonazepam	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Atenolol	Atenolol	24	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Jardiance	Empagliflozin	22	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Amoxicillin	Amoxicillin	18	14
Azithromycin	Azithromycin	18	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Torsemide	Torsemide	18	suppressed
Estradiol	Estradiol	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Premarin	Estrogens, Conjugated	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Linzess	Linaclotide	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Eliquis	Apixaban	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Naproxen	Naproxen	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Baclofen	Baclofen	11	suppressed
Diazepam	Diazepam	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Topiramate	Topiramate	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error